Our research has been built on a history of excellence. We conduct basic, clinical, and outcomes research. Visit our research sections below for more information.
Research Highlights
November 24, 2020
Deletion of bone marrow myeloperoxidase attenuates chronic kidney disease accelerated atherosclerosis
Anna Vachaparampil Mathew MBBS, published her work in the Journal of Biological Chemistry that explores the bone marrow myeloperoxidase in CKD atherosclerosis.
November 5, 2020
Exploring a New Weapon Against COVID-19 Cytokine Storm
Lenar Yessayan, MD and H. David Humes, MD discuss their study that used extracorporeal selective cytopheretic device therapy, developed by Dr. Humes, which helped to wean two patients off ECMO.
September 30, 2020
Uncovering a ‘suPAR’ Culprit Behind Kidney Injury in COVID
Salim Hayek, MD and Subramaniam Pennathur, MD find that hospitalized patients with COVID have high levels of soluble urokinase receptor, a strong predictor of kidney injury.
Listen to Michigan Medicine's team of researchers from various disciplines discuss finding new treatments and new ways to prevent diabetic complications including diabetic kidney disease, diabetic neuropathy, and diabetic retinopathy.
